Pathophysiological classification of chronic rhinosinusitis

被引:25
|
作者
Baraniuk, JN [1 ]
Maibach, H [1 ]
机构
[1] Georgetown Univ, Proteom Lab, Div Rheumatol Allergy & Immunol, Washington, DC 20007 USA
关键词
D O I
10.1186/1465-9921-6-149
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background: Recent consensus statements demonstrate the breadth of the chronic rhinosinusitis (CRS) differential diagnosis. However, the classification and mechanisms of different CRS phenotypes remains problematic. Method: Statistical patterns of subjective and objective findings were assessed by retrospective chart review. Results: CRS patients were readily divided into those with (50/99) and without (49/99) polyposis. Aspirin sensitivity was limited to 17/50 polyp subjects. They had peripheral blood eosinophilia and small airways obstruction. Allergy skin tests were positive in 71% of the remaining polyp subjects. IgE was <10 IU/ml in 8/38 polyp and 20/45 nonpolyp subjects (p = 0.015, Fisher's Exact test). CT scans of the CRS without polyp group showed sinus mucosal thickening (probable glandular hypertrophy) in 28/49, and nasal osteomeatal disease in 21/49. Immunoglobulin isotype deficiencies were more prevalent in nonpolyp than polyp subjects (p < 0.05). Conclusion: CRS subjects were retrospectively classified in to 4 categories using the algorithm of (1) polyp vs. nonpolyp disease, (2) aspirin sensitivity in polyposis, and (3) sinus mucosal thickening vs. nasal osteomeatal disease (CT scan extent of disease) for nonpolypoid subjects. We propose that the pathogenic mechanisms responsible for polyposis, aspirin sensitivity, humoral immunodeficiency, glandular hypertrophy, eosinophilia and atopy are primary mechanisms underlying these CRS phenotypes. The influence of microbial disease and other factors remain to be examined in this framework. We predict that future clinical studies and treatment decisions will be more logical when these interactive disease mechanisms are used to stratify CRS patients.
引用
收藏
页数:14
相关论文
共 50 条
  • [41] Immunopathology of chronic rhinosinusitis
    Kato, Atsushi
    ALLERGOLOGY INTERNATIONAL, 2015, 64 (02) : 121 - 130
  • [42] Biofilms in chronic rhinosinusitis
    Suh, Jeffrey D.
    Cohen, Noam A.
    Palmer, James N.
    CURRENT OPINION IN OTOLARYNGOLOGY & HEAD AND NECK SURGERY, 2010, 18 (01): : 27 - 31
  • [43] Biologics for chronic rhinosinusitis
    Chong, Lee-Yee
    Piromchai, Patorn
    Sharp, Steve
    Snidvongs, Kornkiat
    Webster, Katie E.
    Philpott, Carl
    Hopkins, Claire
    Burton, Martin J.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2021, (03):
  • [44] Chronic rhinosinusitis and superantigens
    Seiberling, KA
    Grammer, L
    Kern, RC
    OTOLARYNGOLOGIC CLINICS OF NORTH AMERICA, 2005, 38 (06) : 1215 - +
  • [45] Pediatric chronic rhinosinusitis
    Ramadan, Hassan H.
    EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2024, 281 (03) : 1131 - 1137
  • [46] Immunomodulators in chronic rhinosinusitis
    Philippe Lavigne
    Stella E.Lee
    世界耳鼻咽喉头颈外科杂志英文版, 2018, (03) : 186 - 192
  • [47] Management of chronic rhinosinusitis
    Anne E. Getz
    Todd T. Kingdom
    Current Respiratory Care Reports, 2014, 3 (4): : 141 - 149
  • [48] Pathogenesis of chronic rhinosinusitis
    Kennedy, DW
    ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY, 2004, 113 (05): : 6 - 9
  • [49] Diagnosis of chronic rhinosinusitis
    Lanza, DC
    ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY, 2004, 113 (05): : 10 - 14
  • [50] Pediatric Chronic Rhinosinusitis
    Silviu-Dan, Fanny
    PEDIATRIC ANNALS, 2014, 43 (08): : E201 - E209